MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.
Astolfi A, Vendemini F, Urbini M, Melchionda F, Masetti R, Franzoni M, Libri V, Serravalle S, Togni M, Paone G, Montemurro L, Bressanin D, Chiarini F, Martelli AM, Tonelli R, Pession A.
Astolfi A, et al. Among authors: vendemini f.
Oncotarget. 2014 Jan 15;5(1):120-30. doi: 10.18632/oncotarget.1337.
Oncotarget. 2014.
PMID: 24334727
Free PMC article.